These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 38319453)
1. Clusterin: a marker and mediator of chemoresistance in colorectal cancer. Hlavca S; Chan WH; Engel RM; Abud HE Cancer Metastasis Rev; 2024 Mar; 43(1):379-391. PubMed ID: 38319453 [TBL] [Abstract][Full Text] [Related]
2. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells. Higa T; Nakayama KI Cancer Sci; 2024 May; 115(5):1370-1377. PubMed ID: 38413370 [TBL] [Abstract][Full Text] [Related]
3. Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy. Frau C; Jamard C; Delpouve G; Guardia GDA; Machon C; Pilati C; Nevé CL; Laurent-Puig P; Guitton J; Galante PAF; Penalva LO; Freund JN; de la Fouchardiere C; Plateroti M Cancer Res; 2021 May; 81(10):2730-2744. PubMed ID: 33741693 [TBL] [Abstract][Full Text] [Related]
5. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer. Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824 [TBL] [Abstract][Full Text] [Related]
6. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894 [TBL] [Abstract][Full Text] [Related]
7. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231 [TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc. Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179 [TBL] [Abstract][Full Text] [Related]
9. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome. Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042 [TBL] [Abstract][Full Text] [Related]
11. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis. Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194 [TBL] [Abstract][Full Text] [Related]
12. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Das PK; Islam F; Lam AK Cells; 2020 Jun; 9(6):. PubMed ID: 32503256 [TBL] [Abstract][Full Text] [Related]
13. A pre-existing population of ZEB2 Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells. Arumugam P; Samson A; Ki J; Song JM Cell Biol Toxicol; 2017 Jun; 33(3):307-321. PubMed ID: 28064403 [TBL] [Abstract][Full Text] [Related]
15. KIN enhances stem cell-like properties to promote chemoresistance in colorectal carcinoma. Yu M; Zhang Z; Yu H; Xue C; Yuan K; Miao M; Shi H Biochem Biophys Res Commun; 2014 May; 448(1):63-9. PubMed ID: 24755081 [TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance. De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206 [TBL] [Abstract][Full Text] [Related]
17. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749 [TBL] [Abstract][Full Text] [Related]